Application and practice of integrated diagnosis of glioma

Application and practice of integrated diagnosis of glioma

Since the publication of the 2016 WHO of Tumors of the Central Nervous System (hereinafter referred to as 2016 WHO), many pathologists face challenges and confusion in "integrated diagnosis" practices of 2016 WHO due to financial or technical problems. In this review, the authors combines...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Zhongguo xian dai shen jing ji bing za zhi 2019-12, Vol.19 (12), p.920-924
Hauptverfasser: Hai⁃nan LI, Zhi LI
Format: Artikel
Sprache:eng
Schlagworte:
glioma
integrated diagnosis (not in mesh)
pathology, molecular
review
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Since the publication of the 2016 WHO of Tumors of the Central Nervous System (hereinafter referred to as 2016 WHO), many pathologists face challenges and confusion in "integrated diagnosis" practices of 2016 WHO due to financial or technical problems. In this review, the authors combines their practice experiences and their understanding of "cIMPACT ⁃ NOW update 1-4", and they discuss the hot issues of "integrated diagnosis", including: how to diagnose astrocytoma and oligodendroglioma, how to diagnose glioma with H3 gene mutation, How to diagnose IDH wild⁃type/H3 wild⁃type glioma and how to diagnose pediatric glioma. It is hopeful for helping Chinese neuropathologists to have a better understanding of glioma diagnostic terminology. DOI：10.3969/j.issn.1672⁃6731.2019.12.003
ISSN:1672-6731